Sign Up Today and Learn More About Arima Genomics Stock
Invest in or calculate the value of your shares in Arima Genomics or other pre-IPO companies through EquityZen's platform.
Arima Genomics Stock
Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
About Arima Genomics Stock
Founded
2015
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Arima Genomics Press Mentions
Stay in the know about the latest news on Arima Genomics
People in the News: Atul Butte Obituary; New Appointments at Arima Genomics, Biocartis, More
genomeweb • Jun 21, 2025
Arima Genomics Closes $22M Series C Financing Round
genomeweb • Jun 21, 2025
Arima Genomics: $22 Million Series C Funding Closed And Tom Willis Named As CEO
pulse2 • Jun 20, 2025
Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing
vcaonline • Jun 19, 2025
Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing
vcaonline • Jun 19, 2025
Arima Genomics Management
Leadership team at Arima Genomics
Senior Vice President of Sales
Gabrielle Raia
President and chief operating officer
Siddarth Selvaraj
Join now and verify your accreditation status to gain access to:
- Arima Genomics Current Valuation
- Arima Genomics Stock Price
- Arima Genomics Management
- Available deals in Arima Genomics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Arima Genomics Cap Table and Funding History by Share Class and Liquidity Preferences
- Arima Genomics Revenue and Financials
- Arima Genomics Highlights
- Arima Genomics Business Model
- Arima Genomics Risk Factors
- Arima Genomics Research Report from SACRA Research
Trading Arima Genomics Stock
How to invest in Arima Genomics stock?
Accredited investors can buy pre-IPO stock in companies like Arima Genomics through EquityZen funds. These investments are made available by existing Arima Genomics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Arima Genomics stock?
Shareholders can sell their Arima Genomics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."